Benjamin Spurgeon: What’s next for Platelet Function Testing?
Benjamin Spurgeon, Associate Director of Diagnostic Hematology Versiti Inc, shared a post on LinkedIn about his a recent article published in RPTH, adding:
“What’s next for Platelet Function Testing?
For too long, patients with bleeding disorders, particularly those who are thrombocytopenic, pediatric, or in remote areas, have had limited access to reliable platelet function testing.
Flow cytometry is helping to expand those possibilities.
By allowing sensitive analysis of platelets in whole blood with small sample volumes, it offers a way to broaden access to advanced testing and explore new insights into platelet function.
Building on my remarks in Washington, D.C., this article in RPTH Journal explores where platelet flow cytometry may be headed.
I consider:
- Why a focused panel of validated markers may provide the greatest clinical relevance
- The potential for scalable, more widely accessible platelet testing”
Title: Markers for platelet function testing by flow cytometry: where are we now? A clinical perspective
Authors: Benjamin E.J. Spurgeon
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda
-
Aug 11, 2026, 05:38Rami Unterman: A Simple New Biomarker for Fibrotic ILDs
-
Aug 11, 2026, 04:10Haroun Gajraj: CLaCS vs Sclerotherapy – What Does the Evidence Show
-
Aug 11, 2026, 02:54Tareq Abadl: The Ultimate Guide to Clinically Significant Antibodies
-
Aug 10, 2026, 17:35Chokri Ben Lamine: Balancing Holistic Care and Precision in Hematology
-
Aug 10, 2026, 17:14Anna Stanizzi: Patient Blood Management as a New Model of Personalized Care
-
Aug 10, 2026, 17:12Odong Christopher: New Research on Ischemic Stroke Prediction in Uganda
-
Aug 10, 2026, 16:58Jeff Szer AM: Advancing the Management of Paroxysmal Nocturnal Hemoglobinuria
-
Aug 10, 2026, 16:51Suebsarn RuksakulpiwatÖ‰ A New Milestone in the Development of the Stroke Risk Screening Scales